Magnet.me - Het slimme netwerk waar studenten en professionals hun stage of baan vinden.
Het slimme netwerk waar studenten en professionals hun stage of baan vinden.
Bouw aan je carrière op Magnet.me
Maak een profiel aan en ontvang slimme aanbevelingen op basis van je gelikete vacatures.
The Biologics Workstream is actively seeking a skilled computational biologist to enhance our team's capabilities in developing antibody-based therapeutics.
This role sits at the intersection of AI, data science, antibody discovery and characterization, thereby necessitating collaboration across various teams specializing in oncology, immunology and advanced computational methods. Your primary objective will be to leverage in silico data to dissect the mode of action (MoA) and assist in the identification of promising antibody candidates.
As a computational biologist within our team, you will be responsible for analyzing large datasets that directly influence our drug discovery and development projects. You'll play a central role in setting up novel models for biologicals, integrate currently available models in our workstream, identify essential parameters for antibody efficacy and drive analytical strategies forward.
Responsibilities
About Oncode Accelerator
The current process to develop cancer therapies is expensive, time-consuming and high-risk. More importantly, newly developed therapies are often only effective in a small group of the intended patient population.
The medical, financial, and societal burden of the disease is growing, and so is the demand for effective, safe and personalized treatments. Preclinical development is a crucial step in advancing a new cancer therapy towards clinical application. However, too many of the innovations that make it through the preclinical development process fail in late-stage clinical trials. Therefore, there is a clear need to increase the likelihood of success.
To truly make a difference in the lives of cancer patients, the preclinical development process needs to be revolutionized. Oncode Accelerator is taking on this challenge, driven by a profound commitment to improving patient outcomes. Our novel approach will allow for earlier predictions of cancer therapy effectiveness and safety, leading to a significantly faster process and better patient outcomes.
Requirements
Het UMC Utrecht wil bijdragen aan een gezond leven en een gezonde maatschappij, ook voor de generaties na ons. Daarvoor is veel kennis nodig. Als academisch ziekenhuis doen we wetenschappelijk onderzoek naar verschillende ziekten en de werking van onze genen.
Deze bedrijfspagina is automatisch gegenereerd en bevat daarom nog weinig informatie. Je vindt meer informatie over ‘bedrijfsnaam’ op hun website: ‘’Carrierewebsite’’
Bekijk ons aanbod:
Resources:
Change language to: English
Deze pagina is geoptimaliseerd voor mensen uit Nederland. Bekijk de versie geoptimaliseerd voor mensen uit het Verenigd Koninkrijk.